InfuSystem Holdings Inc. (INFU) |
|
8.42 0.19 (2.31%)
|
05-16 08:44 |
|
Open: |
8.24 |
Pre. Close: |
8.23 |
|
High:
|
8.53 |
Low:
|
8.15 |
|
Volume:
|
114,525 |
Market Cap:
|
173(M) |
|
|
|
|
InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other alternate site settings comprising home care and home infusion providers, skilled nursing facilities, pain centers, hospital market, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
8.54 - 8.58 |
8.58 - 8.62 |
|
Low:
|
8.05 - 8.1 |
8.1 - 8.14 |
|
Close:
|
8.34 - 8.42 |
8.42 - 8.5 |
|
Technical analysis |
as of: 2022-05-16 8:19:17 AM |
|
Overall:
|
 |
| Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 11.18 One year: 13.06 |
| Support: |
Support1: 7.84 Support2: 6.78 |
| Resistance: |
Resistance1: 9.57 Resistance2: 11.18 |
| Pivot: |
8.19  |
| Moving Average: |
MA(5): 8.39 MA(20): 8.08
MA(100): 11.74  MA(250): 14.67 |
| MACD: |
MACD(12,26): -0.2 Signal(9): -0.3 |
| Stochastic oscillator: |
%K(14,3): 56.3 %D(3): 55.1 |
| RSI: |
RSI(14): 48.3 |
| 52-week: |
High: 21.88 Low: 6.78 |
| Average Vol(K): |
3-Month: 138 (K) 10-Days: 169 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ INFU ] has closed below upper band by 41.5%. Bollinger Bands are 0% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Mon, 16 May 2022
For Penn State, a Talent Infusion Arrives This Summer - Sports Illustrated
Sun, 15 May 2022
InfuSystem Holdings Inc. (NYSEAMERICAN:INFU) Short Interest Update - Defense World
Fri, 13 May 2022
Beyond The Lane Lines: West Australia Gets Aquatic Facility Cash Infusion - SwimSwam
Thu, 12 May 2022
Flint faces insolvency without cash infusion for pensions, CFO warns - MLive.com
Thu, 12 May 2022
Classic Cocktail Recipes using Pineapple Aperol Infusion - WGN TV Chicago
Sat, 07 May 2022
InfuSystem Holdings Inc. (INFU) CEO Rich DiIorio on Q1 2022 Results - Earnings Call Transcript - Seeking Alpha
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Neutral |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Outperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: AMEX |
| Sector: Healthcare |
| Industry: Medical Instruments & Supplies |
| Shares Out. |
21 (M) |
| Shares Float |
16 (M) |
|
% Held by Insiders
|
4.9 (%) |
|
% Held by Institutions
|
68.4 (%) |
|
Shares Short
|
225 (K) |
|
Shares Short P.Month
|
177 (K) |
Stock Financials |
|
EPS
|
0.54 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0.23 |
|
EPS Est Next Year
|
0.28 |
|
Book Value (p.s.)
|
2.25 |
|
Profit Margin (%)
|
11.6 |
|
Operating Margin (%)
|
2.4 |
|
Return on Assets (ttm)
|
1.7 |
|
Return on Equity (ttm)
|
30.8 |
|
Qtrly Rev. Growth
|
5.6 |
|
Gross Profit (p.s.)
|
2.8 |
|
Sales Per Share
|
4.86 |
|
EBITDA (p.s.)
|
0.72 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
22 (M) |
|
Levered Free Cash Flow
|
8 (M) |
Stock Valuations |
|
PE Ratio
|
15.59 |
|
PEG Ratio
|
7 |
|
Price to Book value
|
3.74 |
|
Price to Sales
|
1.73 |
|
Price to Cash Flow
|
7.82 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
